Table 1.
Total cohort N = 28 |
≥0.05m/s decrease in gait speed N = 11 |
<0.05m/s decrease in gait speed N = 17 |
|||||
---|---|---|---|---|---|---|---|
average | SD | average | SD | average | SD | P-value* | |
Age (years) | 64.0 | 10.5 | 60.5 | 8.5 | 66.4 | 11.2 | 0.15 |
Race White Black Other |
14 (50%) 13 (46%) 1(4%) |
3(27%) 7(64%) 1(9%) |
11(65%) 6(35%) 0 |
0.08 |
|||
Gender Male Female |
20 (71%) 8 (29%) |
8 (73%) 3 (27%) |
12(71%) 5(29%) |
1.00 |
|||
Height (cm) | 172.6 | 11.0 | 174.5 | 12.1 | 171.3 | 10.5 | 0.46 |
Weight (kilograms) | 87.1 | 21.7 | 95.9 | 23.1 | 81.4 | 19.4 | 0.08 |
BMI | 29.3 | 7.0 | 31.7 | 7.8 | 27.7 | 6.2 | 0.15 |
Dialysis vintage (years) |
3.9 | 4.0 | 5.4 | 5.6 | 2.9 | 2.3 | 0.11 |
Diabetes | 16 (57.1%) | 8 (72.7) | 8 (47.1) | 0.25 | |||
HTN | 24 (85.7%) | 10 (90.9) | 14 (82.4) | 0.64 | |||
CHF | 10 (35.7%) | 5 (45.5) | 5 (29.40 | 0.44 | |||
CAD | 9 (32.1%) | 3 (27.3) | 6 (35.3) | 0.70 | |||
PVD | 4 (14.3) | 2 (18.2) | 2 (11.8) | 1.00 | |||
Cirrhosis | 2 (7.2) | 0 (0) | 2 (11.8) | 0.51 | |||
Stroke | 4 (14.3) | 2 (18.2) | 1 (11.8) | 1.00 | |||
Serum Albumin | 3.79 | 0.38 | 3.87 | 0.43 | 3.73 | 0.35 | 0.34 |
Serum hemoglobin | 11.00 | 1.01 | 11.40 | 1.04 | 10.74 | 0.92 | 0.09 |
Kt/V | 1.54 | 0.27 | 1.51 | 0.24 | 1.56 | 0.29 | 0.69 |
URR | 76.00 | 5.08 | 75.10 | 3.51 | 76.56 | 5.90 | 0.49 |
Average Pre HD gait speed |
0.76 | 0.21 | 0.77 | 0.22 | 0.76 | 0.21 | 0.92 |
Average post HD Gait speed |
0.71 | 0.21 | 0.63 | 0.19 | 0.76 | 0.21 | 0.10 |
change in gait speed post HD |
−0.06 | 0.08 | −0.14 | 0.06 | 0.00 | 0.03 | n/a |
Falls Efficacy score | 33.15 | 12.67 | 32.18 | 11.73 | 33.81 | 13.61 | 0.75 |
P-values are based on t-test for continuous variables and exact chi-square test for categorical variables.
BMI is body mass index, HTN is hypertension, CHF is congestive heart failure, CAD is coronary artery disease, PVD is peripheral vascular disease, Kt/V is a marker of dialysis clearance and URR is urea reduction ratio.